ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 15
Summary
- Conditions
- Congenital Heart Disease
- Pulmonary Disease
- Pulmonary Regurgitation
- Tetralogy of Fallot
- Transcatheter Pulmonary Valve Replacement (TPVR)
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: Single arm, prospective, multi-center studyMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03130777
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Evan Zahn, MD, FACC, FSCAI Cedars-Sinai Heart Institute
Get Well Soon